XTANT MEDICAL HOLDINGS INC
Public company snapshot, recent ticker-linked headlines, and a path into evidence-backed AI research.
Latest price
$0.28
-3.51%
Alpha Vantage · 10/30/2026
One-year price history
Adjusted daily closes · 252 observations · as of Oct 30, 2026
1 month
-20.0%
3 months
-36.4%
6 months
-49.0%
1 year
-69.6%
Year to date
-64.1%
52-week range
$0.28 – $0.92
Fundamental snapshot
Latest reported period: Jun 30, 2026
Market cap
$39.3M
P/E
-3.5
P/B
1
P/S
0.4
Revenue
$109.53M
Net income
-$11.14M
Diluted EPS
-0.08
Gross margin
59.40%
Net margin
-10.20%
Return on equity
-23.50%
Total debt
$26.01M
Cash
$10.22M
Free cash flow
-$459K
Latest eight reported quarters
Reported quarterly values, newest first
| Period | Revenue | Net income | Gross margin | Net margin | Free cash flow |
|---|---|---|---|---|---|
| Jun 30, 2026 | $23.03M | -$9.41M | 57.90% | -40.90% | -$7.5M |
| Mar 31, 2026 | $20.88M | -$3.09M | 57.30% | -14.80% | -$2.26M |
| Dec 31, 2025 | $32.36M | $57K | 54.90% | 0.20% | $5.01M |
| Sep 30, 2025 | $33.26M | $1.31M | 66.10% | 3.90% | $4.29M |
| Jun 30, 2025 | $35.41M | $3.55M | 68.60% | 10.00% | $959K |
| Mar 31, 2025 | $32.9M | $58K | 61.50% | 0.20% | $135K |
| Dec 31, 2024 | $31.51M | -$3.17M | 50.80% | -10.00% | $98K |
| Sep 30, 2024 | $27.94M | -$5.02M | 58.40% | -18.00% | -$3.73M |
Reported figures can reflect company reporting conventions, restatements, or sector-specific accounting. Verify against filings before relying on a valuation comparison.
Recent XTNT news
All market newsNo ticker-linked stories are in the current archive.